In this daily bar chart of CME, below, we can see a "straight up" rally from late March with prices now poised to make new highs. CME is trading above the rising 200-day moving average line and above the rising 50-day line. The 50-day line is poised to cross above the 200-day line for what is commonly called a (bullish) golden cross. This signal is typically late but can be successful in long-trending markets.
The daily On-Balance-Volume (OBV) line made a peak in early December and declined to a late March low. The OBV line has improved the past two months but it is still below the December zenith and thus not confirming the price gains the past two months.
The Moving Average Convergence Divergence (MACD) oscillator is above the zero line and rising - bullish.
In this weekly bar chart of CME, below, we see positive signals. Prices have doubled in the past three years.
CME is above the rising 40-week moving average line which has done a great job in defining the uptrend and giving buying opportunities every time the line was tested.
The weekly OBV line has made a new high for the move up to confirm the price gains - unlike the daily OBV line.
The weekly MACD oscillator has crossed to the upside above the zero line for an outright buy signal - like the daily signal.
In this Point and Figure chart of CME, below, we can see a large double top breakout at $195.49 with a tentative price target of $243 being projected.
Bottom line strategy: All three of the charts (above) look bullish, so unless there is a sudden reversal I would look for CME to head higher. We might see some sideways movement in the short-run but $200 and $240 are the new upside price targets. Risk a close below $185 and buy strength.